Use of anti-IL-12 antibodies in transplantation rejection

Xian Chang Li

Use of anti-IL-12 antibodies in transplantation rejection

Research output: Patent

Abstract

Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.

Original language	English (US)
Patent number	WO1999022766 A3
IPC	US
Priority date	10/31/97
State	Published - Aug 5 1999

Cite this

@misc{69b3a4a67a374cd7a4c1afc0404689e1,

title = "Use of anti-IL-12 antibodies in transplantation rejection",

abstract = "Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.",

author = "Li, {Xian Chang}",

year = "1999",

month = aug,

day = "5",

language = "English (US)",

type = "Patent",

note = "WO1999022766 A3; US",

}

TY - PAT

T1 - Use of anti-IL-12 antibodies in transplantation rejection

AU - Li, Xian Chang

PY - 1999/8/5

Y1 - 1999/8/5

N2 - Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.

AB - Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.

M3 - Patent

M1 - WO1999022766 A3

ER -

Use of anti-IL-12 antibodies in transplantation rejection

Abstract

Fingerprint

Cite this